Literature DB >> 7586226

Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine.

M R Bennett1, D F Gibson, S M Schwartz, J F Tait.   

Abstract

Apoptosis of vascular smooth muscle cells has recently been demonstrated to occur in vitro and in vivo. Uptake of apoptotic cells into adjacent normal cells appears to be rapid and specific. We have investigated binding and phagocytosis of apoptotic vascular smooth muscle cells by normal smooth muscle cell monolayers. Vascular smooth muscle cells were infected with the proto-oncogene c-myc or the adenovirus E1A gene, induced to undergo apoptosis in low-serum conditions, and then incubated with normal smooth muscle cells. Apoptosis was accompanied by a marked increase in exposure of phosphatidylserine on the outer surface of the cell, which was recognized by binding to annexin V. Liposomes containing phosphatidylserine but not phosphatidylinositol inhibited uptake of apoptotic cells in a dose-dependent manner to a maximum of 50% inhibition; annexin V also inhibited the uptake of apoptotic cells in a dose-dependent and calcium-dependent manner. Binding of apoptotic bodies did not appear to be mediated by endogenous annexin V, as evidenced by the inability of an antibody to annexin V to inhibit uptake. Smooth muscle cells were also able to recognize exposed phosphatidylserine on other cell types, as judged by their ability to bind erythrocytes having a high degree of exposed phosphatidylserine. We conclude that smooth muscle cells express phosphatidylserine during apoptosis, and this exposure partly mediates binding and phagocytosis of dead cells. This mechanism may be important in promoting rapid cell removal in the vessel wall.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7586226     DOI: 10.1161/01.res.77.6.1136

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  38 in total

Review 1.  Clearance: the last and often forgotten stage of apoptosis.

Authors:  V A Fadok
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

2.  Early apoptosis in intestinal and diffuse gastric carcinomas.

Authors:  Hong-Ping Zhou; Xu Wang; Nan-Zheng Zhang
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

Review 3.  Do inflammatory cells participate in mammary gland involution?

Authors:  Jenifer Monks; F Jon Geske; Lisa Lehman; Valerie A Fadok
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

4.  Autologous apoptotic cell engulfment stimulates chemokine secretion by vascular smooth muscle cells.

Authors:  Diana M Fries; Richard Lightfoot; Michael Koval; Harry Ischiropoulos
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

Review 5.  Roles of the innate immune system in mammary gland remodeling during involution.

Authors:  Kamran Atabai; Dean Sheppard; Zena Werb
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-03       Impact factor: 2.673

Review 6.  Platelet-derived microparticles and the potential of glycoprotein IIb/IIIa antagonists in treating acute coronary syndrome.

Authors:  Ximing Li; Hongliang Cong
Journal:  Tex Heart Inst J       Date:  2009

7.  Phosphatidylserine-mediated adhesion of T-cells to endothelial cells.

Authors:  J Qu; L A Conroy; J H Walker; F B Wooding; J A Lucy
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

8.  Current imaging strategies in rheumatoid arthritis.

Authors:  Merissa N Zeman; Peter Jh Scott
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

9.  Annexin A5-functionalized nanoparticle for multimodal imaging of cell death.

Authors:  Rui Zhang; Miao Huang; Min Zhou; Xiaoxia Wen; Qian Huang; Chun Li
Journal:  Mol Imaging       Date:  2013-05       Impact factor: 4.488

10.  Molecular imaging of cell death in vivo by a novel small molecule probe.

Authors:  Revital Aloya; Anat Shirvan; Hagit Grimberg; Ayelet Reshef; Galit Levin; Dvora Kidron; Avi Cohen; Ilan Ziv
Journal:  Apoptosis       Date:  2006-12       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.